A U-M Rogel Cancer study provides an updated, more comprehensive look at trends for this rare, aggressive form of breast cancer over the last four decades.

The new approach could help doctors to separate aggressive stage 0 breast cancer from non-aggressive forms, sparing some women unnecessary mastectomies.

Though they often receive little fanfare, postdocs are critical to the success of the Rogel Cancer Center’s research programs.

A first-ever report describes how overall gains against cancer are not benefiting some racial and ethnic groups – and how COVID-19 may be making it worse.

A new study shows tumor cells eat up a key amino acid, depriving immune cells of it, which prevents them from fighting off cancer.

The analysis, done in three colon cancer cell lines, is believed to be the first to profile transcriptome-level changes in response to DNA damage across individual cells.